SSG
GEVA

Summit Securities Group’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Summit Securities Group’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-100
Closed -$9K – 607
2014
Q4 		$9K Buy
+100
New +$9K ﹤0.01% 391
2013
Q4 		– Sell
-100
Closed -$6K – 527
2013
Q3 		$6K Sell
100
-400
-80% -$24K ﹤0.01% 258
2013
Q2 		$21K Buy
+500
New +$21K 0.01% 213